We found a similar percentage of chromosome gains and losses at the MPZL3 locus in the TCGA ovarian adenocarcinoma dataset (Supplementary Fig. S1A), leading us to question how MPZL3 influences ovarian cancer development and progression. This evidence concerns the gene MPZL3 and ovarian adenocarcinoma.